Our Pediatric Sickle Cell Program through Smilow Cancer Hospital is comprised of a team of experts focused on the care of pediatric patients with sickle cell disease. Infants, children and adolescents with pediatric sickle cell diseases are treated by a multidisciplinary team of board-certified pediatric hematologists, advanced practice providers, psychologists, pediatric pain specialists and social workers. In collaboration with the Pediatric Blood and Marrow Transplantation Program, we offer bone marrow transplants to patients with sickle cell disease.
Sickle cell disease is an inherited blood disease that affects red blood cells, changing their shape and texture. This change in red blood cells prevents blood from flowing properly in the body and can affect organ systems and lead to chronic pain. Symptoms and complications can increase with age.
Our specialized team partners with the patient and their family to focus on self-care education, surveillance, and management of the disease’s complications. They work closely with Smilow Cancer Hospital’s adult hematology specialists to ensure a smooth transition from pediatric to adult care. Our physicians pioneered the diagnosis and treatment of pulmonary complications associated with sickle cell disease and launched the first national clinical trial for therapy.
Sickle cell disease is caused by a mutation in the HBB gene that is inherited from both parents. If only one parent passes a mutated HBB gene, the person will only be a carrier of the sickle cell gene and will not have active symptoms.
A baby with sickle cell disease may not experience symptoms until 4 – 6 months of age. Symptoms in children can vary, but may include:
Sickle cell disease is diagnosed through a blood test. Often newborns are screened after birth or, if there is a family history, testing can be done in utero through amniocentesis or chorionic villus sampling. If someone was not screened at birth or diagnosed but is suspected to have sickle cell disease, certain tests can be performed, including:
Treatment for sickle cell disease is aimed at pain management and maintenance therapies. These treatments include:
In addition to traditional approaches to pain management, patients receive instruction in complementary, non-pharmaceutical techniques such as diaphragmatic breathing taught with biofeedback, guided imagery, distraction, and cognitive behavior strategies for the management of emotional distress.
The bone marrow in a person with sickle cell disease produces red blood cells that contain an abnormal form of hemoglobin, leading to complications. In a bone marrow (stem cell) transplant, the patient’s bone marrow is replaced with blood-forming stem cells from a donor who does not have sickle cell disease. This can help to stop further sickle cell disease complications from developing.
With MyChart, you can view your test results and doctor's comments from the comfort of your own home.
Go To MyChart
Yale New Haven Health is proud to be affiliated with the prestigious Yale University and its highly ranked Yale School of Medicine.
